Head and Neck Cancer Clinical Trials | Center for Cancer Research
A clinical trial studying the combination of two chemotherapy drugs, cisplatin and docetaxel, either alone or in combination with the immunotherapeutic anti-HPV vaccine PRGN-2009 in patient with newly-diagnosed, untreated HPV-positive oropharyngeal cancer before surgery.
Evidence level: Feltételezés / hírjelzés. Nincs önálló tudományos bizonyíték.
Related signals
- Spatial Profiling of the Head and Neck Squamous Cell Carcinoma Microenvironment: Reshaping Our Understanding and Therapeutic Opportunities
- Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancer
- Review Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review
- Preclinical models in head and neck squamous cell carcinoma
- CAR-Based Cell Therapy in Head and Neck Cancer: A Comprehensive Review on Clinical Applicability